Flures
Fluorescein
Injection 20% w/v

Description

Flures contains Fluorescein sodium equivalent to Fluorescein 20% w/v. It is a sterile aqueous solution to use intravenously as a diagnostic aid.

• Pyrogen free

• Preservative free

• Reduced side effects

• Safe and effective

Indications

Fluorescein sodium is indicated for ophthalmic angiography and angioscopy in diagnostic examination of the fundus; in evaluation of the iris vasculature; to differentiate between viable and non-viable tissue; to assess aqueous flow; in differential diagnosis of malignant and non-malignant tumors; and in determination of circulation time and adequacy of the circulation.

Contraindications

Contraindicated in persons those who have shown hypersensitivity to any component of this preparation.

Warnings & Precautions

• Care must be taken to avoid extravasation during injection as the high pH of fluorescein solution can result in severe local tissue damage.

• Discontinue usage and pay medical attention if any of the following symptoms are seen in the patient. Sloughing of the skin, superficial phlebitis, subcutaneous granuloma, and toxic neuritis along the median curve in the antecubital area.

• Complications resulting from extravasation can cause severe pain in the arm for several hours.

• Appropriate consideration of the cardiac status of the patient must be made before administration of fluorescein sodium injection.

• Appropriate consideration of the cardiac status of the patient must be made before administration of fluorescein sodium injection.

• Caution is to be exercised in patients with a history of hypersensitivity, allergies, or asthma.

• Caution should be exercised when fluorescein sodium injection is administered to a pregnant or a nursing woman.

• Safety and effectiveness in children have not been established.

Adverse Effects

The following adverse reactions have been reported rarely after using fluorescein sodium injection, cardiac arrest, acute myocardial infarction, basilar artery ischemia, thrombophlebitis at the injection site, severe shock, and other signs and symptoms of hypersensitivity, convulsions, syncope, pyrexia, transient dyspnea, angioneurotic edema, moderate to marked nausea and headache, gastrointestinal distress, slight dizziness, urticaria and pruritus.

Dosage & Administration

Inject contents of ampoule rapidly into the antecubital vein. In 9 to 14 seconds luminescence appears in the retinal and choroidal vessels which can be observed by standard viewing equipment. Please read IFU for more information and instruction.

Supply

Available in sterile 3ml glass ampoule (pack of 10 ampoules per box).

Storage

Store at temperature not exceeding 35°C & protect from light.